1-18 of 18
Authors: Florian Ringel
Save search
Sort by
Journal Article

CTNI-85. FINAL RESULTS FROM N2M2/NOA-20

PDF
Wolfgang Wick and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii117, https://doi.org/10.1093/neuonc/noae165.0451
Published: 11 November 2024
Journal Article

CTIM-04. MODULATION OF THE INTRATUMORAL IMMUNE MICROENVIRONMENT BY LOCAL THERAPY WITH NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA

PDF
Michael Burger and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii85, https://doi.org/10.1093/neuonc/noae165.0338
Published: 11 November 2024
Journal Article

Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection’s limited influence on overall survival, ATRX as molecular prognosticator

PDF
Alice Ryba and others
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1479–1493, https://doi.org/10.1093/neuonc/noae061
Published: 20 March 2024
Journal Article

CTNI-40. A MULTICENTER, RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS IN INTRACRANIAL H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA IN ADULTS

PDF
Alice Ryba and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v83–v84, https://doi.org/10.1093/neuonc/noad179.0322
Published: 10 November 2023
Journal Article

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

PDF
Johannes Weller and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii71, https://doi.org/10.1093/neuonc/noac209.274
Published: 14 November 2022
Journal Article

BIOM-08. DNA METHYLATION-BASED SUBGROUPING PREDICTS SURVIVAL BENEFIT FROM LOMUSTINE/TEMOZOLOMID COMBINATION THERAPY IN MGMT PROMOTOR-METHYLATED GLIOBLASTOMA

PDF
Johannes Weller and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi11, https://doi.org/10.1093/neuonc/noab196.039
Published: 12 November 2021
Journal Article

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

PDF
Niklas Schäfer and others
Neuro-Oncology, Volume 20, Issue 7, July 2018, Pages 975–985, https://doi.org/10.1093/neuonc/nox204
Published: 07 November 2017
Journal Article

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial

PDF
Ulrich Herrlinger and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi13–vi14, https://doi.org/10.1093/neuonc/nox168.049
Published: 06 November 2017
Journal Article

NCOG-10. FACTORS INFLUENCING NEUROCOGNITIVE FUNCTION IN PATIENTS WITH NEUROEPITHELIAL TUMORS

PDF
Jens Gempt and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi139–vi140, https://doi.org/10.1093/neuonc/nox168.571
Published: 06 November 2017
Journal Article

TMIC-49. POTASSIUM CHANNEL KIR4.1 AND GLUTAMINE SYNTHETASE ARE DYSREGULATED IN GLIOMA

PDF
Lucas Schirmer and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Pages vi253–vi254, https://doi.org/10.1093/neuonc/nox168.1037
Published: 06 November 2017
Journal Article

NCOG-03. PERSONALITY TRAITS IN PATIENTS WITH NEUROEPITHELIAL TUMORS – A PROSPECTIVE STUDY

PDF
Jens Gempt and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi138, https://doi.org/10.1093/neuonc/nox168.564
Published: 06 November 2017
Journal Article

Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients

PDF
Javier M Figueroa and others
Neuro-Oncology, Volume 19, Issue 11, November 2017, Pages 1494–1502, https://doi.org/10.1093/neuonc/nox085
Published: 27 April 2017
Journal Article

SURG-03. RESECTION OF HIGHLY LANGUAGE-ELOQUENT BRAIN LESIONS PURELY BASED ON rTMS LANGUAGE MAPPING WITHOUT AWAKE SURGERY

PDF
Sebastian Ille and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi191, https://doi.org/10.1093/neuonc/now212.804
Published: 07 November 2016
Journal Article

BMET-02. METASTASES AFFECTING THE MOTOR ELOQUENT CORTEX SHOULD BE RESECTED WITH PREOPERATIVE MOTOR MAPPING DATA BY nTMS

PDF
Sandro M. Krieg and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi26, https://doi.org/10.1093/neuonc/now212.102
Published: 07 November 2016
Journal Article

Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection

PDF
Florian Ringel and others
Neuro-Oncology, Volume 18, Issue 1, January 2016, Pages 96–104, https://doi.org/10.1093/neuonc/nov145
Published: 04 August 2015
Journal Article

Preoperative motor mapping by navigated transcranial magnetic brain stimulation improves outcome for motor eloquent lesions Get access

PDF
Sandro M. Krieg and others
Neuro-Oncology, Volume 16, Issue 9, September 2014, Pages 1274–1282, https://doi.org/10.1093/neuonc/nou007
Published: 09 February 2014
Journal Article

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma Get access

PDF
Andrea Schäfer and others
Neuro-Oncology, Volume 14, Issue 12, December 2012, Pages 1452–1464, https://doi.org/10.1093/neuonc/nos270
Published: 06 November 2012
Journal Article

Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity Get access

PDF
Michael Rasper and others
Neuro-Oncology, Volume 12, Issue 10, October 2010, Pages 1024–1033, https://doi.org/10.1093/neuonc/noq070
Published: 13 July 2010